Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension

被引:60
作者
Sondermeijer, B
Kompa, A
Komesaroff, P
Krum, H
机构
[1] Monash Univ, Alfred Hosp, Dept Med, Melbourne, Vic 3004, Australia
[2] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
基金
英国医学研究理事会;
关键词
urotensin-II; hypertension; microcirculation; iontophoresis; laser Doppler velocimetry; pharmacology;
D O I
10.1016/j.amjhyper.2005.03.748
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Plasma levels of urotensin-II (U-II) have been found to be elevated in patients with essential hypertension. However, the consequence of activation of the U-II system have not been previously determined in these patients. We therefore compared the effect of exogenous U-II administration on vascular tone in hypertensive patients (n = 13) and normotensive subjects (n = 14). Methods: The effect of U-II on vascular tone was determined in the forearm skin microcirculation using iontophoresis to administer the drug and laser Doppler velocimetry to measure microvascular response. Results: The U-II administration was associated with a dose-dependent vasodilator response from baseline in normotensive subjects (U-II 1 X 10(-12) mol/L, 609 +/- 164; U-II 1 X 10(-9) mol/L, 839 +/- 216; U-II, 1 X 10(-7) mol/L, 1249 +/- 228 arbitrary flux units; P < .0005). A dose-dependent vasoconstrictor response was observed in hypertensive patients compared to baseline (U-II 1 X 10(-12) mol/L, 60 +/- 212; U-II 1 X 10(-9) mol/L, -288 +/- 172; U-II, 1 X 10(-7) mol/L, -607 +/- 165 arbitrary flux units; P < .005). Differences in flow between the two groups were significant at the 1 X 10(-9) mol/L and 1 X 10(-7) mol/L dose levels (P < .001). In contrast, there was no significant difference in flux between baseline and U-II in either group (or between groups) when the opposite polarity was applied. Conclusions: The demonstration of opposing effects of exogenous U-II in patients with hypertension and normal subjects suggests that U-II may be contributory to the increased vascular tone of these patients.
引用
收藏
页码:1195 / 1199
页数:5
相关论文
共 29 条
[1]   Urotensin II: a new mediator in cardiopulmonary regulation? [J].
Affolter, J ;
Webb, DJ .
LANCET, 2001, 358 (9284) :774-775
[2]   Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[3]   Urotensin-II: a novel systemic hypertensive factor in the cat [J].
Behm, DJ ;
Doe, CPA ;
Johns, DG ;
Maniscalco, K ;
Stankus, GP ;
Wibberley, A ;
Willette, RN ;
Douglas, SA .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (03) :274-280
[4]   Urotensin II evokes potent vasoconstriction in humans in vivo [J].
Böhm, F ;
Pernow, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) :25-27
[5]   Effects of human urotensin II in isolated vessels of various species;: comparison with other vasoactive agents [J].
Camarda, V ;
Rizzi, A ;
Calò, G ;
Gendron, G ;
Perron, SI ;
Kostenis, E ;
Zamboni, P ;
Mascoli, F ;
Regoli, D .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (02) :141-149
[6]   Plasma concentration of urotensin II is raised in hypertension [J].
Cheung, BMY ;
Leung, R ;
Man, YB ;
Wong, LYF .
JOURNAL OF HYPERTENSION, 2004, 22 (07) :1341-1344
[7]  
Conlon JM, 1996, J EXP ZOOL, V275, P226, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<226::AID-JEZ14>3.0.CO
[8]  
2-H
[9]   Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord [J].
Coulouarn, Y ;
Lihrmann, I ;
Jegou, S ;
Anouar, Y ;
Tostivint, H ;
Beauvillain, JC ;
Conlon, JM ;
Bern, HA ;
Vaudry, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15803-15808
[10]   From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function [J].
Douglas, SA ;
Dhanak, D ;
Johns, DG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (02) :76-85